Pyrotinib Versus Placebo in Combination with Trastuzumab and Docetaxel As First Line Treatment in Patients with HER2 Positive Metastatic Breast Cancer (PHILA): Randomised, Double Blind, Multicentre, Phase 3 Trial.Fei Ma,Min Yan,Wei Li,Quchang Ouyang,Zhongsheng Tong,Yuee Teng,Yongsheng Wang,Shusen Wang,Cuizhi Geng,Ting Luo,Jincai Zhong,Qingyuan Zhang,Qiang Liu,Xiaohua Zeng,Tao Sun,Qinguo Mo,Hu Liu,Ying Cheng,Jing Cheng,Xiaojia Wang,Jianyun Nie,Jin Yang,Xinhong Wu,Xinshuai Wang,Huiping Li,Changsheng Ye,Fangli Dong,Shuchao Wu,Xiaoyu Zhu,Binghe XuBMJ（2023）引用 26|浏览55AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
